The 3rd U-PGx Personalized Medicine Public Day will be organized in Patras, Greece.

One of the most important prerequisites of the successful implementation of pharmacogenomics into the clinic is the increase of the general public’s awareness over the benefits of pharmacogenomics in rationalizing drug use.

Recognizing this fact, the Golden Helix Foundation organizes in Patras, Greece the 3rd U-PGx Personalized Medicine Public Day. The theme of the meeting will be “Pharmacogenomics and Personalized Medicine” and will be organized at the Agora Argyri on September 26th, 2019 (09:00 – 14:00 and 17:00 – 20:00 p.m.) and is part of the dissemination and outreaching activities of the Ubiquitous Pharmacogenomics (U-PGx) project, funded by the European Commission (H2020-668353).

In particular, there will be three main events, as part of the 3rd Personalized Medicine Public Day:

  1. 09:00 – 14:00: Practical demonstration of the 2MoBiL Portable Molecular Biology Laboratory and its role in Personalized Medicine education for school students,
  2. 17:00 – 20:00: Main event: Presentations and roundtable discussion of Personalized Medicine notions, and
  3. 20:00 – 22:00: Bioscience night: Interactive discussions on Personalized Medicine topics.

This event is meant for the general public, patient organisations, regulators, insurers and policy makers.

Registration is FREE-OF-CHARGE.

On behalf of the Organizing Committe

Co-organized by
    

Funded by:

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 668353.

 Under the auspices of:

 

The 3rd U-PGx Personalized Medicine Public Day will be organized in Patras, Greece.

One of the most important prerequisites of the successful implementation of pharmacogenomics into the clinic is the increase of the general public’s awareness over the benefits of pharmacogenomics in rationalizing drug use.

Recognizing this fact, the Golden Helix Foundation organizes in Patras, Greece the 3rd U-PGx Personalized Medicine Public Day. The theme of the meeting will be “Pharmacogenomics and Personalized Medicine” and will be organized at the Agora Argyri on September 26th, 2019 (09:00 – 14:00 and 17:00 – 20:00 p.m.) and is part of the dissemination and outreaching activities of the Ubiquitous Pharmacogenomics (U-PGx) project, funded by the European Commission (H2020-668353).

In particular, there will be three main events, as part of the 3rd Personalized Medicine Public Day:

  1. 09:00 – 14:00: Practical demonstration of the 2MoBiL Portable Molecular Biology Laboratory and its role in Personalized Medicine education for school students,
  2. 17:00 – 20:00: Main event: Presentations and roundtable discussion of Personalized Medicine notions, and
  3. 20:00 – 22:00: Bioscience night: Interactive discussions on Personalized Medicine topics.

This event is meant for the general public, patient organisations, regulators, insurers and policy makers.

Registration is FREE-OF-CHARGE.

On behalf of the Organizing Committe

Co-organized by    Funded by: This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 668353.

 Under the auspices of:

Clinical application of pharmacogenomics knowledge will result in less ‘trial and error’ prescribing and more efficacious, safer and cost-effective drug therapy. However, despite the major advances in pharmacogenomics and several commercially available pharmacogenomics tests, its application in routine patient care remains very limited. The U-PGx consortium will address major challenges and obstacles for implementation of pharmacogenomics testing in patient care, taking into account the diversity of healthcare systems and citizens across Europe. Specifically, U-PGx will investigate if the emerging approach of pre-emptive genotyping of an entire panel of important pharmacogenomics markers is cost-effective and results in a better outcome for patients. With the pre-emptive pharmacogenomics testing approach data on multiple important pharmacogenes are collected prospectively and embedded into the patients’ electronic record. Typically, it alerts prescribers and pharmacists through electronic clinical decision support systems when a drug is ordered or dispensed for a patient with an at-risk genotype. The new model of personalised medicine through pre-emptive pharmacogenomics testing will be conducted at a large scale in seven existing European health care environments in the Netherlands, Spain, UK, Italy, Austria, Greece, and Slovenia.

Invited Speakers

Moderator:

Klelia Charissi

Speakers (in alphabetical order):

Despoina Aroni (Post-doctoral Research fellow, University of Patras)

George P. Patrinos (Professor, University of Patras)

Maria Skokou (Psychiatrist, Patras University Hospital)

Eunice Stefanou (Head, Laboratory of Medical Genetics, Patras University Hospital)

Evangelia-Eirini Tsermpini (Academic Scholar, University of Patras)

Scientific Program 

(Lectures will be delivered in Greek)

A.

09:00 – 14:00 The 2MoBiL Portable Molecular Biology Laboratory

Practical demonstration of the 2MoBiL Portable Molecular Biology Laboratory and its role in Personalized Medicine education in primary and high-school students

B.

17:00 – 20:00 Main event – 3rd Personalized Medicine Public Day

Presentations and roundtable discussions on Personalized Medicine

17:00 – 17:30: Registrations

17:30 – 17:50: Personalized Medicine: The future is here

George P. Patrinos, Professor, University of Patras

17:50 – 18:10: Individualizing treatment modalities in Psychiatry

Maria Skokou, Psychiatrist, Patras University Hospital

18:10 – 18:30: Genetics and the diagnosis of inherited diseases

Eunice StefanouHead; Laboratory of Medical Genetics, Patras University Hospital

18:30 – 18:45: Personalized Medicine and social awareness: The role of social worker

Despoina AroniPost-doctoral Research fellow, University of Patras

18:45 – 20:00: Round table discussion (coordinated by Ms. Klelia Charissi)

Topics to be discussed:

– How drug treatment individualisation can contribute towards minimising adverse drug reactions?

– Which genetic tests are scientifically sound?

– Which genetic diseases can be accurately diagnosed?

– Which are the ethical, social and financial implications of personalised medicine interventions?

C.

20:00 – 22:00 Bioscience night – Personalized Medicine is here

Interactive presentation of Personalised Medicine topics in Cafe Locale (Patras)

 Click here to download the 1st announcement (content in Greek)

Registration

The registration is closed